(Q38837821)

6 September 2017

1 reference

title

Anti-Microtubule Drugs (English)

1 reference

6 September 2017

Stefan Florian

1

1 reference

PubMed ID

27193863

6 September 2017

Timothy J Mitchison

series ordinal

2

1 reference

PubMed ID

27193863

6 September 2017

language of work or name

English

0 references

publication date

1 January 2016

1 reference

Methods in Molecular Biology

6 September 2017

19

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

6 September 2017

1413

1 reference

6 September 2017

403-421

1 reference

Development of a novel class of tubulin inhibitors with promising anticancer activities

6 September 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Effects of Taxotere on murine and human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Eribulin -- a review of preclinical and clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

A phase I study of eribulin mesylate (E7389), a mechanistically novel inhibitor of microtubule dynamics, in patients with advanced solid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Structure of tubulin at 6.5 A and location of the taxol-binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Refined structure of alpha beta-tubulin at 3.5 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Structural basis for the regulation of tubulin by vinblastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Mode of action of chemotherapy in vivo on human acute leukemia—II. Vincristine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Microtubules as a target for anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Microtubule-binding agents: a dynamic field of cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

The mechanism of action of colchicine. Binding of colchincine-3H to cellular protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Amino-acid composition of "Tubulin" constituting microtubules of sperm flagella

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Prevention of recurrent pericarditis with colchicine in 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Treatment of hereditary autoinflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Colchicine in clinical medicine. A guide for internists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Stathmin and Interfacial Microtubule Inhibitors Recognize a Naturally Curved Conformation of Tubulin Dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

THE MECHANISM OF COLCHICINE INHIBITION OF MITOSIS. I. KINETICS OF INHIBITION AND THE BINDING OF H3-COLCHICINE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Characterization of microtubule assembly in porcine brain extracts by viscometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Targeting tumour vasculature: the development of combretastatin A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

A model for cleavage plane determination in early amphibian and fish embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Plk1 negatively regulates PRC1 to prevent premature midzone formation before cytokinesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Cell polarization during monopolar cytokinesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Isolation of the beta-tubulin gene from yeast and demonstration of its essential function in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

The spindle assembly checkpoint in budding yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Phase 2 study of T138067-sodium in patients with malignant glioma: Trial of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Phase II trial of T138067, a novel microtubule inhibitor, in patients with metastatic, refractory colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Mitosis is not a key target of microtubule agents in patient tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

The proliferation rate paradox in antimitotic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

How Taxol/paclitaxel kills cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Evidence that microtubule depolymerization early in the cell cycle is sufficient to initiate DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Taxol stabilizes microtubules in mouse fibroblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

DEPDC1/LET-99 participates in an evolutionarily conserved pathway for anti-tubulin drug-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

The role of microtubule dynamics in growth cone motility and axonal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Microtubular crystals in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Promotion of microtubule assembly in vitro by taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Relationships between the structure of taxol analogs and their antimitotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Structure of the alpha beta tubulin dimer by electron crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Identification of a novel force-generating protein, kinesin, involved in microtubule-based motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Cells satisfy the mitotic checkpoint in Taxol, and do so faster in concentrations that stabilize syntelic attachments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

A taxol-dependent procedure for the isolation of microtubules and microtubule-associated proteins (MAPs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Fluorescent taxoids as probes of the microtubule cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Cell cycle-dependent changes in microtubule dynamics in living cells expressing green fluorescent protein-alpha tubulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Fluorogenic probes for live-cell imaging of the cytoskeleton.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Macromolecular interaction of halichondrin B analogues eribulin (E7389) and ER-076349 with tubulin by analytical ultracentrifugation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Microtubule-interfering Agents Activate c-Jun N-terminal Kinase/Stress-activated Protein Kinase through Both Ras and Apoptosis Signal-regulating Kinase Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3542-0_25

Isolierung neuer Stoffe aus den Samen der Herbstzeitlose Colchicum autumnaleL. Substanzen der Herbstzeitlose und ihre Derivate. 12. Mitteilung

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/HLCA.19500330629

10.1007/978-1-4939-3542-0_25

9 March 2024

Identifiers

DOI

1 reference

6 September 2017

1 reference

PubMed ID

27193863